Eventide Asset Management’s Beta Bionics BBNX Stock Holding History
Bought
Maintained
Sold
Other funds holding BBNX
Eventide Asset Management's BBNX Position: Q3 2026 in Review
Eventide Asset Management increased its Beta Bionics (BBNX) stake by 13% in Q3 2026, buying an estimated $14.2M and bringing the position to 7,044,630 shares worth $134M. The position accounts for 1.87% of the portfolio, ranked #6.
Eventide Asset Management first reported a position in BBNX in Q1 2025 and has held it in 7 quarters since. The position peaked at $152M in Q4 2025. 153 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.
- Eventide Asset Management held 7,044,630 shares of Beta Bionics worth $134M as of Q3 2026.
- Eventide Asset Management bought 790,957 Beta Bionics shares in Q3 2026, an estimated $14.2M.
- Beta Bionics made up 1.87% of Eventide Asset Management's portfolio in Q3 2026, its #6 holding.
- Eventide Asset Management first reported a position in Beta Bionics in Q1 2025 and has held it in 7 quarters since.
- Eventide Asset Management's Beta Bionics position peaked at $152M in Q4 2025.
- 153 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.
Based on Eventide Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.